Correlation Between Vigil Neuroscience and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and Cue Biopharma, you can compare the effects of market volatilities on Vigil Neuroscience and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Cue Biopharma.
Diversification Opportunities for Vigil Neuroscience and Cue Biopharma
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Vigil and Cue is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Cue Biopharma go up and down completely randomly.
Pair Corralation between Vigil Neuroscience and Cue Biopharma
Given the investment horizon of 90 days Vigil Neuroscience is expected to under-perform the Cue Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Vigil Neuroscience is 2.31 times less risky than Cue Biopharma. The stock trades about -0.08 of its potential returns per unit of risk. The Cue Biopharma is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 66.00 in Cue Biopharma on September 2, 2024 and sell it today you would earn a total of 56.00 from holding Cue Biopharma or generate 84.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vigil Neuroscience vs. Cue Biopharma
Performance |
| Timeline |
| Vigil Neuroscience |
| Cue Biopharma |
Vigil Neuroscience and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vigil Neuroscience and Cue Biopharma
The main advantage of trading using opposite Vigil Neuroscience and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Vigil Neuroscience vs. Tff Pharmaceuticals | Vigil Neuroscience vs. Eliem Therapeutics | Vigil Neuroscience vs. Inhibrx | Vigil Neuroscience vs. Enliven Therapeutics |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |